APO Research
Talk to an analyst

APO RESEARCH · REPORT

Commercial Drug Procurement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Commercial Drug Procurement Market Outlook and Growth Opportunities 2026

3 March 2026194 pages

Choose your research edition.

Industry ResearchCommercial Drug Procurement Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Commercial Drug Procurement Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Commercial Drug Procurement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Commercial Drug Procurement Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Commercial Drug Procurement Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Commercial Drug Procurement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Commercial Drug Procurement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Commercial Drug Procurement market include Viseven, Bionical Emas, Almac, BMclinical, Myonex, McKesson, Parexel, Patheon and Clinigen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Commercial Drug Procurement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Commercial Drug Procurement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Commercial Drug Procurement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Commercial Drug Procurement market.

Commercial Drug Procurement Segment by Company

Viseven

Bionical Emas

Almac

BMclinical

Myonex

McKesson

Parexel

Patheon

Clinigen

UPS Healthcare

Catalent

Endpoint Clinical

Signant Health

YPrime

Commercial Drug Procurement Segment by Type

Tender

Direct Procurement

Competitive Negotiation

Others

Commercial Drug Procurement Segment by Application

Life Sciences

Clinical Trials

Others

Commercial Drug Procurement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Commercial Drug Procurement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Commercial Drug Procurement key companies, revenue, market share, and recent developments.

3. To split the Commercial Drug Procurement breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Commercial Drug Procurement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Commercial Drug Procurement significant trends, drivers, influence factors in global and regions.

6. To analyze Commercial Drug Procurement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Commercial Drug Procurement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Commercial Drug Procurement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Commercial Drug Procurement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Commercial Drug Procurement industry.

Chapter 3: Detailed analysis of Commercial Drug Procurement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Commercial Drug Procurement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Commercial Drug Procurement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Commercial Drug Procurement Industry Trends Table 2. Commercial Drug Procurement Industry Drivers Table 3. Commercial Drug Procurement Industry Opportunities and Challenges Table 4. Commercial Drug Procurement Industry Restraints Table 5. Global Commercial Drug Procurement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Commercial Drug Procurement Revenue Share by Company (2021-2026) Table 7. Global Commercial Drug Procurement Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Commercial Drug Procurement Key Company Manufacturing Base & Headquarters Table 9. Global Commercial Drug Procurement Company, Product Type & Application Table 10. Global Commercial Drug Procurement Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Commercial Drug Procurement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tender Table 15. Significant Companies of Direct Procurement Table 16. Significant Companies of Competitive Negotiation Table 17. Significant Companies of Others Table 18. Global Commercial Drug Procurement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Commercial Drug Procurement Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Commercial Drug Procurement Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Commercial Drug Procurement Sales Value Share by Type (2021-2026) Table 22. Global Commercial Drug Procurement Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Life Sciences Table 24. Significant Companies of Clinical Trials Table 25. Significant Companies of Others Table 26. Global Commercial Drug Procurement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Commercial Drug Procurement Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Commercial Drug Procurement Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Commercial Drug Procurement Sales Value Share by Application (2021-2026) Table 30. Global Commercial Drug Procurement Sales Value Share by Application (2027-2032) Table 31. Global Commercial Drug Procurement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Commercial Drug Procurement Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Commercial Drug Procurement Sales Value Share by Region (2021-2026) Table 34. Global Commercial Drug Procurement Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Commercial Drug Procurement Sales Value Share by Region (2027-2032) Table 36. Global Commercial Drug Procurement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Commercial Drug Procurement Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Commercial Drug Procurement Sales Value Market Share by Country (2021-2026) Table 39. Global Commercial Drug Procurement Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Commercial Drug Procurement Sales Value Market Share by Country (2027-2032) Table 41. Viseven Company Information Table 42. Viseven Business Overview Table 43. Viseven Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Viseven Commercial Drug Procurement Product Portfolio Table 45. Viseven Recent Development Table 46. Bionical Emas Company Information Table 47. Bionical Emas Business Overview Table 48. Bionical Emas Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Bionical Emas Commercial Drug Procurement Product Portfolio Table 50. Bionical Emas Recent Development Table 51. Almac Company Information Table 52. Almac Business Overview Table 53. Almac Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Almac Commercial Drug Procurement Product Portfolio Table 55. Almac Recent Development Table 56. BMclinical Company Information Table 57. BMclinical Business Overview Table 58. BMclinical Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. BMclinical Commercial Drug Procurement Product Portfolio Table 60. BMclinical Recent Development Table 61. Myonex Company Information Table 62. Myonex Business Overview Table 63. Myonex Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Myonex Commercial Drug Procurement Product Portfolio Table 65. Myonex Recent Development Table 66. McKesson Company Information Table 67. McKesson Business Overview Table 68. McKesson Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. McKesson Commercial Drug Procurement Product Portfolio Table 70. McKesson Recent Development Table 71. Parexel Company Information Table 72. Parexel Business Overview Table 73. Parexel Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Parexel Commercial Drug Procurement Product Portfolio Table 75. Parexel Recent Development Table 76. Patheon Company Information Table 77. Patheon Business Overview Table 78. Patheon Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Patheon Commercial Drug Procurement Product Portfolio Table 80. Patheon Recent Development Table 81. Clinigen Company Information Table 82. Clinigen Business Overview Table 83. Clinigen Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Clinigen Commercial Drug Procurement Product Portfolio Table 85. Clinigen Recent Development Table 86. UPS Healthcare Company Information Table 87. UPS Healthcare Business Overview Table 88. UPS Healthcare Commercial Drug Procurement Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. UPS Healthcare Commercial Drug Procurement Product Portfolio Table 90. UPS Healthcare Recent Development Table 91. Catalent Company Information Table 92. Catalent Business Overview Table 93. Catalent Commercial Drug Procurement Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Catalent Commercial Drug Procurement Product Portfolio Table 95. Catalent Recent Development Table 96. Endpoint Clinical Company Information Table 97. Endpoint Clinical Business Overview Table 98. Endpoint Clinical Commercial Drug Procurement Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Endpoint Clinical Commercial Drug Procurement Product Portfolio Table 100. Endpoint Clinical Recent Development Table 101. Signant Health Company Information Table 102. Signant Health Business Overview Table 103. Signant Health Commercial Drug Procurement Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Signant Health Commercial Drug Procurement Product Portfolio Table 105. Signant Health Recent Development Table 106. YPrime Company Information Table 107. YPrime Business Overview Table 108. YPrime Commercial Drug Procurement Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. YPrime Commercial Drug Procurement Product Portfolio Table 110. YPrime Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Commercial Drug Procurement Product Image Figure 2. Global Commercial Drug Procurement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 4. Global Commercial Drug Procurement Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tender Image Figure 8. Direct Procurement Image Figure 9. Competitive Negotiation Image Figure 10. Others Image Figure 11. Global Commercial Drug Procurement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Commercial Drug Procurement Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Commercial Drug Procurement Sales Value Share by Type (2021-2032) Figure 14. Life Sciences Image Figure 15. Clinical Trials Image Figure 16. Others Image Figure 17. Global Commercial Drug Procurement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Commercial Drug Procurement Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Commercial Drug Procurement Sales Value Share by Application (2021-2032) Figure 20. Global Commercial Drug Procurement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Commercial Drug Procurement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Commercial Drug Procurement Sales Value (2021-2032) & (US$ Million) Figure 23. North America Commercial Drug Procurement Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Commercial Drug Procurement Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Commercial Drug Procurement Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Commercial Drug Procurement Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Commercial Drug Procurement Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Commercial Drug Procurement Sales Value (2021-2032) & (US$ Million) Figure 29. South America Commercial Drug Procurement Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Commercial Drug Procurement Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Commercial Drug Procurement Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Commercial Drug Procurement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Tender
  • Direct Procurement
  • Competitive Negotiation
  • Others
Applications
  • Life Sciences
  • Clinical Trials
  • Others
Companies covered
  • Viseven
  • Bionical Emas
  • Almac
  • BMclinical
  • Myonex
  • McKesson
  • Parexel
  • Patheon
  • Clinigen
  • UPS Healthcare
  • Catalent
  • Endpoint Clinical
  • Signant Health
  • YPrime

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Commercial Drug Procurement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Commercial Drug Procurement Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Commercial Drug Procurement Market Dynamics
  1. 2.1 Commercial Drug Procurement Industry Trends
  2. 2.2 Commercial Drug Procurement Industry Drivers
  3. 2.3 Commercial Drug Procurement Industry Opportunities and Challenges
  4. 2.4 Commercial Drug Procurement Industry Restraints
3 Commercial Drug Procurement Market by Company
  1. 3.1 Global Commercial Drug Procurement Company Revenue Ranking in 2025
  2. 3.2 Global Commercial Drug Procurement Revenue by Company (2021-2026)
  3. 3.3 Global Commercial Drug Procurement Company Ranking (2024-2026)
  4. 3.4 Global Commercial Drug Procurement Company Manufacturing Base and Headquarters
  5. 3.5 Global Commercial Drug Procurement Company Product Type and Application
  6. 3.6 Global Commercial Drug Procurement Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Commercial Drug Procurement Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Commercial Drug Procurement Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Commercial Drug Procurement Market by Type
  1. 4.1 Commercial Drug Procurement Type Introduction
  2. 4.1.1 Tender
  3. 4.1.2 Direct Procurement
  4. 4.1.3 Competitive Negotiation
  5. 4.1.4 Others
  6. 4.2 Global Commercial Drug Procurement Sales Value by Type
  7. 4.2.1 Global Commercial Drug Procurement Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Commercial Drug Procurement Sales Value by Type (2021-2032)
  9. 4.2.3 Global Commercial Drug Procurement Sales Value Share by Type (2021-2032)
5 Commercial Drug Procurement Market by Application
  1. 5.1 Commercial Drug Procurement Application Introduction
  2. 5.1.1 Life Sciences
  3. 5.1.2 Clinical Trials
  4. 5.1.3 Others
  5. 5.2 Global Commercial Drug Procurement Sales Value by Application
  6. 5.2.1 Global Commercial Drug Procurement Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Commercial Drug Procurement Sales Value by Application (2021-2032)
  8. 5.2.3 Global Commercial Drug Procurement Sales Value Share by Application (2021-2032)
6 Commercial Drug Procurement Regional Value Analysis
  1. 6.1 Global Commercial Drug Procurement Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Commercial Drug Procurement Sales Value by Region (2021-2032)
  3. 6.2.1 Global Commercial Drug Procurement Sales Value by Region: 2021-2026
  4. 6.2.2 Global Commercial Drug Procurement Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Commercial Drug Procurement Sales Value (2021-2032)
  7. 6.3.2 North America Commercial Drug Procurement Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Commercial Drug Procurement Sales Value (2021-2032)
  10. 6.4.2 Europe Commercial Drug Procurement Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Commercial Drug Procurement Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Commercial Drug Procurement Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Commercial Drug Procurement Sales Value (2021-2032)
  16. 6.6.2 South America Commercial Drug Procurement Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Commercial Drug Procurement Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Commercial Drug Procurement Sales Value Share by Country, 2025 VS 2032
7 Commercial Drug Procurement Country-level Value Analysis
  1. 7.1 Global Commercial Drug Procurement Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Commercial Drug Procurement Sales Value by Country (2021-2032)
  3. 7.2.1 Global Commercial Drug Procurement Sales Value by Country (2021-2026)
  4. 7.2.2 Global Commercial Drug Procurement Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Commercial Drug Procurement Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Commercial Drug Procurement Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Commercial Drug Procurement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Viseven
  2. 8.1.1 Viseven Company Information
  3. 8.1.2 Viseven Business Overview
  4. 8.1.3 Viseven Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Viseven Commercial Drug Procurement Product Portfolio
  6. 8.1.5 Viseven Recent Developments
  7. 8.2 Bionical Emas
  8. 8.2.1 Bionical Emas Company Information
  9. 8.2.2 Bionical Emas Business Overview
  10. 8.2.3 Bionical Emas Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bionical Emas Commercial Drug Procurement Product Portfolio
  12. 8.2.5 Bionical Emas Recent Developments
  13. 8.3 Almac
  14. 8.3.1 Almac Company Information
  15. 8.3.2 Almac Business Overview
  16. 8.3.3 Almac Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Almac Commercial Drug Procurement Product Portfolio
  18. 8.3.5 Almac Recent Developments
  19. 8.4 BMclinical
  20. 8.4.1 BMclinical Company Information
  21. 8.4.2 BMclinical Business Overview
  22. 8.4.3 BMclinical Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BMclinical Commercial Drug Procurement Product Portfolio
  24. 8.4.5 BMclinical Recent Developments
  25. 8.5 Myonex
  26. 8.5.1 Myonex Company Information
  27. 8.5.2 Myonex Business Overview
  28. 8.5.3 Myonex Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Myonex Commercial Drug Procurement Product Portfolio
  30. 8.5.5 Myonex Recent Developments
  31. 8.6 McKesson
  32. 8.6.1 McKesson Company Information
  33. 8.6.2 McKesson Business Overview
  34. 8.6.3 McKesson Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  35. 8.6.4 McKesson Commercial Drug Procurement Product Portfolio
  36. 8.6.5 McKesson Recent Developments
  37. 8.7 Parexel
  38. 8.7.1 Parexel Company Information
  39. 8.7.2 Parexel Business Overview
  40. 8.7.3 Parexel Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Parexel Commercial Drug Procurement Product Portfolio
  42. 8.7.5 Parexel Recent Developments
  43. 8.8 Patheon
  44. 8.8.1 Patheon Company Information
  45. 8.8.2 Patheon Business Overview
  46. 8.8.3 Patheon Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Patheon Commercial Drug Procurement Product Portfolio
  48. 8.8.5 Patheon Recent Developments
  49. 8.9 Clinigen
  50. 8.9.1 Clinigen Company Information
  51. 8.9.2 Clinigen Business Overview
  52. 8.9.3 Clinigen Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Clinigen Commercial Drug Procurement Product Portfolio
  54. 8.9.5 Clinigen Recent Developments
  55. 8.10 UPS Healthcare
  56. 8.10.1 UPS Healthcare Company Information
  57. 8.10.2 UPS Healthcare Business Overview
  58. 8.10.3 UPS Healthcare Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  59. 8.10.4 UPS Healthcare Commercial Drug Procurement Product Portfolio
  60. 8.10.5 UPS Healthcare Recent Developments
  61. 8.11 Catalent
  62. 8.11.1 Catalent Company Information
  63. 8.11.2 Catalent Business Overview
  64. 8.11.3 Catalent Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Catalent Commercial Drug Procurement Product Portfolio
  66. 8.11.5 Catalent Recent Developments
  67. 8.12 Endpoint Clinical
  68. 8.12.1 Endpoint Clinical Company Information
  69. 8.12.2 Endpoint Clinical Business Overview
  70. 8.12.3 Endpoint Clinical Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Endpoint Clinical Commercial Drug Procurement Product Portfolio
  72. 8.12.5 Endpoint Clinical Recent Developments
  73. 8.13 Signant Health
  74. 8.13.1 Signant Health Company Information
  75. 8.13.2 Signant Health Business Overview
  76. 8.13.3 Signant Health Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Signant Health Commercial Drug Procurement Product Portfolio
  78. 8.13.5 Signant Health Recent Developments
  79. 8.14 YPrime
  80. 8.14.1 YPrime Company Information
  81. 8.14.2 YPrime Business Overview
  82. 8.14.3 YPrime Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  83. 8.14.4 YPrime Commercial Drug Procurement Product Portfolio
  84. 8.14.5 YPrime Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst